Plastic & Reconstructive Surgery · 2006 · 132 citations · 16 references
MedicinePlastic SurgerySurgeryReconstructive Oral SurgeryReconstructive SurgeryRegenerative MedicineFacial Plastic SurgeryFacial RejuvenationSkin RejuvenationFillersInjectable Rejuvenation TherapiesPoly(lactic Acid)Poly-l-lactic Acid FillersProduct Safety ProfileSoft Tissue Facial RecontouringSoft Tissue Volume RestorationWrinkle Correction
BACKGROUND: Facial rejuvenation has traditionally centered on the correction of ptosis, lines, and wrinkles, typically achieved by surgical tightening of the skin or by injecting soft-tissue fillers. In recent years, volumetric augmentation and recontouring have been recognized as fundamentally important aspects of facial rejuvenation. METHODS: An overview of volume restoration and recontouring is presented. A literature search was also conducted to identify the injectable products representing potential treatment options for facial recontouring. The author also presents the results of his extensive experience with poly-L-lactic acid in the treatment of thousands of cosmetic patients in Europe, with special emphasis on the efficacy and tolerability of this product. RESULTS: Several injectable treatment options can be used to recontour and restore volume, to the face and beyond. All of these products, except calcium hydroxylapatite and poly-L-lactic acid, are nonresorbable, offering permanent volume augmentation, but with the increased risk of severe foreign-body reactions. Poly-L-lactic acid provides semipermanent results and has been documented to offer volume augmentation with a favorable safety profile. Achieving good efficacy and safety is dependent on the appropriate reconstitution of the product and adhering to the correct injection technique. CONCLUSIONS: Injectable products offer a flexible means of recontouring the face and localized regions beyond the face. The potential of some of these products is supported by a wealth of published results and clinical experience, helping the physician to identify the most appropriate treatment for their patient.
16
Biodegradable poly(lactic acid) polymers
R. K. Kulkarni, Evan G. Moore, Andrew F. Hegyeli et al. · Journal of Biomedical Materials Research · 1971 · 798 citations
Sylwester Gogolewski, Miloš Jovanović, S. M. Perren et al. · Journal of Biomedical Materials Research · 1993 · 544 citations
Graeme Moyle, Christine Baldwin, B. Langroudi et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2003 · 128 citations